Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00133029 · ClinicalTrials.gov registry record · Phase 4
The Timing of Prophylactic Antibiotics in Cesarean Section and the Risk of Post-operative Febrile Morbidity
A Phase 4 study, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- Phase 4
- Development phase
NCT00133029: Clinical Trial Phase 4 study, sponsored by University of Pennsylvania.
NCT00133029 is a Phase 4 study that was terminated before completion, run by University of Pennsylvania. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00133029, a Phase 4 study, was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- Phase 4
- Development phase
Study Summary
The purpose of this study is to determine whether the timing of prophylactic antibiotic administration for cesarean section (immediate preoperative versus intraoperative administration) impacts the rate of postoperative febrile morbidity. The specific aim of the project is to test the hypothesis that preoperative antibiotic administration will decrease the rate of composite postoperative febrile morbidity.
Interventions
- DRUG Timing of prophylactic antibiotic administration
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-07 |
| Est. Completion | 2006-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00133029
The ClinicalTrials.gov registry entry for NCT00133029 describes a study currently listed as terminated, categorized as Phase 4. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Timing of prophylactic antibiotic administration is the first listed.
NCT00133029 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00133029 about?
NCT00133029 is a clinical study titled "The Timing of Prophylactic Antibiotics in Cesarean Section and the Risk of Post-operative Febrile Morbidity". The purpose of this study is to determine whether the timing of prophylactic antibiotic administration for cesarean section (immediate preoperative versus intraoperative administration) impacts the rate of postoperative febrile morbidity. The specific aim of the project is to test the hypothesis tha...
What is the current status of trial NCT00133029?
This trial is currently terminated. It is a Phase 4 study. The study started on 2004-07. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00133029?
The interventions under investigation include: Timing of prophylactic antibiotic administration (DRUG).
Who is sponsoring clinical trial NCT00133029?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.